Annual SG&A
$8.53 M
+$1.20 M+16.29%
31 December 2023
Summary:
Acurx Pharmaceuticals annual selling, general & administrative expenses is currently $8.53 million, with the most recent change of +$1.20 million (+16.29%) on 31 December 2023. During the last 3 years, it has risen by +$6.14 million (+256.02%). ACXP annual SG&A is now -20.86% below its all-time high of $10.78 million, reached on 31 December 2021.ACXP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.62 M
-$672.80 K-29.30%
30 September 2024
Summary:
Acurx Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.62 million, with the most recent change of -$672.80 thousand (-29.30%) on 30 September 2024. Over the past year, it has dropped by -$142.60 thousand (-8.07%). ACXP quarterly SG&A is now -59.16% below its all-time high of $3.98 million, reached on 30 June 2021.ACXP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$237.07 M
-$16.44 M-7.45%
30 September 2024
Summary:
Acurx Pharmaceuticals TTM selling, general & administrative expenses is currently -$237.07 million, with the most recent change of -$16.44 million (-7.45%) on 30 September 2024. Over the past year, it has dropped by -$244.26 million (-3397.19%). ACXP TTM SG&A is now -1617.86% below its all-time high of $11.25 million, reached on 31 March 2022.ACXP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACXP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.3% | -8.1% | -3397.2% |
| 3 y3 years | +256.0% | -53.8% | -2593.3% |
| 5 y5 years | - | - | - |
ACXP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -20.9% | +256.0% | -53.8% | at low | -513.5% | at low |
| 5 y | 5 years | -20.9% | +256.0% | -59.2% | +216.7% | -1617.9% | at low |
| alltime | all time | -20.9% | +256.0% | -59.2% | +216.7% | -1617.9% | at low |
Acurx Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.62 M(-29.3%) | $9.91 M(-1.4%) |
| June 2024 | - | $2.30 M(-18.7%) | $10.06 M(+6.2%) |
| Mar 2024 | - | $2.82 M(-11.0%) | $9.47 M(+11.0%) |
| Dec 2023 | $8.53 M(+16.3%) | $3.17 M(+79.6%) | $8.53 M(+18.7%) |
| Sept 2023 | - | $1.77 M(+3.3%) | $7.19 M(-2.5%) |
| June 2023 | - | $1.71 M(-9.5%) | $7.37 M(+0.0%) |
| Mar 2023 | - | $1.89 M(+3.3%) | $7.37 M(+0.5%) |
| Dec 2022 | $7.34 M | $1.83 M(-6.3%) | $7.34 M(-1.1%) |
| Sept 2022 | - | $1.95 M(+14.2%) | $7.42 M(-17.4%) |
| June 2022 | - | $1.71 M(-7.7%) | $8.99 M(-20.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.85 M(-3.1%) | $11.25 M(+4.3%) |
| Dec 2021 | $10.78 M(+349.9%) | $1.91 M(-45.6%) | $10.78 M(+13.4%) |
| Sept 2021 | - | $3.52 M(-11.6%) | $9.51 M(+43.0%) |
| June 2021 | - | $3.98 M(+187.6%) | $6.65 M(+108.7%) |
| Mar 2021 | - | $1.38 M(+117.5%) | $3.19 M(+32.9%) |
| Dec 2020 | $2.40 M(-1.0%) | $635.50 K(-2.9%) | $2.40 M(+36.1%) |
| Sept 2020 | - | $654.60 K(+27.7%) | $1.76 M(+59.1%) |
| June 2020 | - | $512.60 K(-13.8%) | $1.11 M(+86.2%) |
| Mar 2020 | - | $594.40 K | $594.40 K |
| Dec 2019 | $2.42 M | - | - |
FAQ
- What is Acurx Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual SG&A year-on-year change?
- What is Acurx Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly SG&A year-on-year change?
- What is Acurx Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals TTM SG&A year-on-year change?
What is Acurx Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ACXP is $8.53 M
What is the all time high annual SG&A for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual selling, general & administrative expenses is $10.78 M
What is Acurx Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ACXP annual selling, general & administrative expenses has changed by +$1.20 M (+16.29%)
What is Acurx Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ACXP is $1.62 M
What is the all time high quarterly SG&A for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $3.98 M
What is Acurx Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ACXP quarterly selling, general & administrative expenses has changed by -$142.60 K (-8.07%)
What is Acurx Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ACXP is -$237.07 M
What is the all time high TTM SG&A for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high TTM selling, general & administrative expenses is $11.25 M
What is Acurx Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ACXP TTM selling, general & administrative expenses has changed by -$244.26 M (-3397.19%)